会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • Method of identifying risk for thyroid disorder
    • Verfahren zur Feststellung des RisikosfürSchilddrüsenkrankheit
    • EP2538217A1
    • 2012-12-26
    • EP12176625.7
    • 2008-02-15
    • Genzyme Corporation
    • Margolin, David H.
    • G01N33/50G01N33/53G01N33/74G01N33/68
    • G01N33/6854G01N33/5047G01N33/6893G01N2333/635G01N2333/70592G01N2800/046
    • A method for identifying a patient that is at risk for developing a thyroid disorder that occurs subsequent to treatment with a regimen that depletes lymphocytes, comprising determining whether antibodies directed against thyroid peroxidase or thyroid microsomes are present in the patient, wherein if the antibodies are present in the patient then the patient is at increased risk for developing a thyroid disorder. A particular embodiment is a method for identifying a patient with multiple sclerosis that is at risk for developing a thyroid disorder that occurs subsequent to treatment with a regimen that depletes CD52-positive cells, comprising determining whether antibodies directed against thyroid peroxidase or thyroid microsomes are present in the patient, wherein if the antibodies are present in the patient then the patient is at risk for developing the thyroid disorder.
    • 一种用于鉴定在用消耗淋巴细胞的方案治疗后发生甲状腺疾病的风险的患者的方法,包括确定是否存在针对甲状腺过氧化物酶或甲状腺微粒体的抗体存在于患者体内,其中如果存在抗体 在患者身上,患者发生甲状腺功能障碍的风险增加。 一个特定的实施方案是用于鉴定患有多发性硬化症的患者,该患者处于发生甲状腺疾病的风险中,所述甲状腺疾病在用消耗CD52阳性细胞的方案治疗后发生,包括确定是否存在针对甲状腺过氧化物酶或甲状腺微粒体的抗体 在患者体内,如果抗体存在于患者中,则患者处于发展甲状腺疾病的风险中。